Will you have Quincke's disease with Keflex - from FDA reports

Summary

Quincke's disease is found among people who take Keflex, especially for people who are female, 10-19 old also take medication Sterile Water, and have Anaphylaxis. This study is created by eHealthMe based on reports of 9,977 people who have side effects when taking Keflex from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on cephalexin (the active ingredients of Keflex) and Keflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Quincke's disease are also considered in the study.

What is Keflex?

Keflex has active ingredients of cephalexin. It is often used in infection. (latest outcomes from Keflex 10,824 users)

What is Quincke's disease?

Quincke's disease (a form of localized swelling of the deeper layers of the skin and fatty tissues beneath the skin) has been reported by people with hereditary angioedema, preventive health care, pain, high blood pressure, anaphylaxis (latest reports from 6,900 Quincke's disease patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 08, 2019

9,977 people reported to have side effects when taking Keflex.
Among them, 8 people (0.08%) have Quincke's disease


Number of reports submitted per year:

Could Keflex cause Quincke's disease?

Gender of people who have Quincke's disease when taking Keflex *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Quincke's disease when taking Keflex *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 50 %
  • 20-29: 25 %
  • 30-39: 25 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  1. Preventive Health Care: 2 people, 25.00%
  2. Immune System Disorder: 2 people, 25.00%
  3. Complement Factor Abnormal: 2 people, 25.00%
  4. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 25.00%
  5. Nasal Abscess (pusormation in nose): 1 person, 12.50%
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 12.50%

Top co-used drugs for these people *:

  1. Sterile Water: 4 people, 50.00%
  2. Claritin: 3 people, 37.50%
  3. Epipen: 3 people, 37.50%
  4. Synthroid: 3 people, 37.50%
  5. Metformin: 2 people, 25.00%
  6. Melatonin: 2 people, 25.00%
  7. Firazyr: 2 people, 25.00%
  8. Insulin: 2 people, 25.00%
  9. Bactrim: 2 people, 25.00%
  10. Rocephin: 2 people, 25.00%

Top other side effects for these people *:

  1. Hospitalisation: 2 people, 25.00%
  2. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 25.00%
  3. Skin Infection: 1 person, 12.50%
  4. Prescribed Overdose: 1 person, 12.50%
  5. Pharyngeal Oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal): 1 person, 12.50%
  6. Nosocomial Infection (infection from hospital): 1 person, 12.50%
  7. Nasal Abscess (pusormation in nose): 1 person, 12.50%
  8. Loss Of Consciousness: 1 person, 12.50%
  9. Laryngeal Oedema (swelling of larynx): 1 person, 12.50%
  10. Hypersensitivity: 1 person, 12.50%

* Approximation only. Some reports may have incomplete information.


Do you have Quincke's disease while taking Keflex?

You are not alone:




Related publications that referenced our studies

Related studies

Drugs that are associated with Quincke's disease
Quincke's disease (567 drugs)
Could your condition cause Quincke's disease
Quincke's disease (356 conditions)
Keflex side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Keflex
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Keflex with similar drugs


What would happen?

Predict new side effects and undetected conditions when you take Keflex and have Quincke's disease



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.